SCHOTT Pharma AG & Co. KGaA header image

SCHOTT Pharma AG & Co. KGaA

1SXP

Equity

ISIN DE000A3ENQ51 / Valor 128964250

Xetra (2026-04-23)
EUR 15.20-0.65%

SCHOTT Pharma AG & Co. KGaA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

SCHOTT Pharma AG & Co. KGaA, a subsidiary of SCHOTT AG, specializes in the production of drug containment and delivery systems, including pharmaceutical syringes, cartridges, vials, and ampoules. With a global presence in 34 countries and 16 GMP-compliant manufacturing sites, the company produces over 13 billion drug containers annually, catering to the needs of the pharmaceutical industry. Employing more than 4,700 professionals across North America, Europe, Asia, and Latin America, SCHOTT Pharma collaborates with leading industry partners to ensure the safe, fast, and reliable delivery of medicines. The company operates under the ownership of the Carl Zeiss Foundation and is headquartered in Mainz, Germany. In the fiscal year 2021, SCHOTT Pharma contributed to SCHOTT AG's overall sales of 2.5 billion euros, leveraging its expertise in borosilicate glass and high-grade pharmaceutical COC polymer to meet diverse drug formulation requirements.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-36.3%1Y
%3Y
%5Y

Performance

34.7%1Y
37.9%3Y
37.9%5Y

Volatility

Market cap

2681 M

Market cap (USD)

Daily traded volume (Shares)

94,990

Daily traded volume (Shares)

1 day high/low

25.1 / 24.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

OKYO Pharma Limited
OKYO Pharma Limited OKYO Pharma Limited Valor: 127195533
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.85%USD 1.59
CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.11%USD 56.76
LivaNova PLC
LivaNova PLC LivaNova PLC Valor: 28726218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.05%USD 65.14
Galapagos NV
Galapagos NV Galapagos NV Valor: 3542077
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.58%USD 28.68
Amylyx Pharmaceuticals Inc
Amylyx Pharmaceuticals Inc Amylyx Pharmaceuticals Inc Valor: 115580129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.14%USD 17.32
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
20.49%USD 23.82
Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Edgewise Therapeutics Inc Valor: 110444153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.92%USD 31.23
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.77%CHF 324.90
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.19%CHF 127.80
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.59%CHF 86.90